The business idea for Zovec is to develop and market second-generation Borrelia vaccines, vaccination regime and diagnostics based on own extensive intellectual property together with newly established gene maps of the bacteria.
The project controls an unusually extensive IPR portfolio containing a critical mass of issued patents which jointly define a unique niche within which the company has a freedom to operate. This opportunity includes going after potential infringers in order to collect fees and royalties justified by the IPR union.
Döbelsgatan 8B, SE- 90330 Umeå, Sweden
Phone: +4670 - 650 72 39